KLA insider sale: 511 vested restricted shares to be sold on 08/05/2025

Rhea-AI Filing Summary

Form: Form 144 filed for KLA Corporation (KLAC) discloses a proposed sale of 511 common shares via Fidelity Brokerage Services on 08/05/2025 on NASDAQ with an aggregate market value of $468,587. The filing reports 132,241,430 shares outstanding.

Acquisition & consideration: The 511 shares are reported acquired on 08/05/2025 by restricted stock vesting from the issuer and the payment is classified as compensation. The filing also lists two prior sales by the same seller in the past three months: 39 shares on 07/02/2025 for $34,768.50 and 320 shares on 08/04/2025 for $286,960.00. The form includes standard attestation language and a section for 10b5-1 plan date (no date provided).

Insights

Financial Analyst

TL;DR: Filing discloses sale of 511 vested shares (aggregate value $468,587) and two recent small disposals; information is factual and routine.

The Form 144 shows a proposed sale of 511 common shares through Fidelity on 08/05/2025 with an aggregate market value of $468,587. The shares are identified as acquired on 08/05/2025 via restricted stock vesting and payment is listed as compensation. The filing also records two recent sales by the same individual: 39 shares (07/02/2025) for $34,768.50 and 320 shares (08/04/2025) for $286,960.00. From an investor viewpoint, the form supplies the standard disclosure metrics required for insider sales.

Corporate Governance Expert

TL;DR: Disclosure indicates immediate sale of vested restricted stock and includes attestation; no 10b5-1 plan adoption date is provided on the form.

The filing explicitly identifies the 511 shares as arising from restricted stock vesting and lists compensation as the payment nature. The form contains the standard representation that the signer does not possess undisclosed material adverse information. A field for the Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1 is present but no date is shown. These elements are procedural disclosures typical for insider sales filings.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	511	468587.00	132241430	08/05/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/05/2025	Restricted Stock Vesting	Issuer			511	08/05/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Virendra Kirloskar One Technology Drive Milpitas CA 95035	Common	07/02/2025	39	34768.50
Virendra Kirloskar One Technology Drive Milpitas CA 95035	Common	08/04/2025	320	286960.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the KLAC Form 144 filed on 08/05/2025 disclose?

The filing discloses a proposed sale of 511 common shares via Fidelity on 08/05/2025 on NASDAQ with an aggregate market value of $468,587.

Who is identified as the seller in the filing?

The past-sales table lists Virendra Kirloskar (address shown) as the seller for prior transactions in the past three months.

How were the 511 shares acquired according to the form?

The 511 shares are shown as acquired on 08/05/2025 by restricted stock vesting from the issuer and payment is classified as compensation.

What prior insider sales are reported in the past three months?

Two prior sales are reported: 39 shares on 07/02/2025 for $34,768.50 and 320 shares on 08/04/2025 for $286,960.00.

Does the filing indicate a 10b5-1 trading plan adoption date?

The form contains a field for the Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1, but no date is provided on this filing.